학술논문
Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs.
Document Type
journal article
Author
Source
Journal of Rheumatology; Aug2021, Vol. 48 Issue 8, p1230-1238, 9p
Subject
Language
ISSN
0315162X
Abstract
Copyright of Journal of Rheumatology is the property of Journal of Rheumatology Publishing Co. Ltd. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)